{
    "doi": "https://doi.org/10.1182/blood.V108.11.1255.1255",
    "article_title": "Endothelial Microparticles (EMP) and Their Interactions with Leukocytes in HIV Infected Patients with Optimal Response to Highly Active Antiretroviral Therapy (HAART). ",
    "article_date": "November 16, 2006",
    "session_type": "Poster Sessions",
    "abstract_text": "Background: HIV infection has been associated with endothelial dysfunction. Endothelial microparticles (EMP) are informative markers of endothelial cell status and can exert transcellular effects in leukocytes. No previous studies have assessed EMP and their interactions with leukocytes in HIV-infected patients. Methods: We studied 29 patients (mean age = 42.1\u00b17 years) with HIV infection on HAART who demonstrated an optimal viral and immunological response (CD4+ cell count>200 /mm 3 and < 50 viral copies/ml by PCR analysis). Patients with diabetes, smoking, thrombotic, cardiovascular or malignant disease were excluded. We used age- and gender-matched healthy controls. Using flow cytometry, we measured free EMP identified by: Expression of CD31 and lack of expression of CD42b (EMP 31 ); E-selectin expression (EMP 62E ); CD51 expression (EMP 51 ), or; CD54 expression (EMP 54 ). EMP 62E - and EMP 54 -leukocyte conjugates were measured based on the detection of E-selectin or CD54, respectively, coexpressed with CD45 in neutrophils, monocytes and lymphocytes. Results: Results are summarized in Table 1. Levels of free EMP 31 , EMP 51 , EMP 54 and EMP 62E did not differ significantly between the groups. However, a very significant elevation of EMP 54 -Lymphocyte Conjugates (p=0.001) and a trend towards an elevation of EMP 62E -Lymphocyte Conjugates was seen in HIV-infected patients. Furthermore, EMP 63E -lymphocyte conjugates significantly correlated with the CD4+ cell count (R=-0.64; p=0.03). Conversely, HIV-infected patients demonstrated significantly lower levels of EMP 62E -Monocyte Conjugates (p=0.0005) and a trend toward lower levels of EMP 54 -Monocyte Conjugates (p=0.08). Conclusions: HIV infected patients with optimal response to HAART demonstrate an increased number of circulating EMP-lymphocyte conjugates with decreased number of EMP-monocyte conjugates. We speculate that viral EMP-receptor upregulation in lymphocytes and/or downregulation in monocytes could account for this phenomenon. EMP-lymphocyte conjugates inversely correlate with the CD4 count. The role of increased EMP-lymphocyte interactions in viral spread and lymphocyte dysfunction/apoptosis in HIV infected-patients requires further investigation. Levels of endothelial microparticles (EMPs) and EMP-leukocyte conjugates in HIV+ patients compared to controls.  . HIV+ Patients . Control . P value . MFI=Mean fluorescence intensity EMP31, counts/\u03bcL (IQR) 680 (497\u20131112) 1018 (566-1691) 0.16 EMP51, counts/\u03bcL (IQR) 114 (75\u2013141.5) 114 (96\u2013143) 0.59 EMP62E, counts/\u03bcL (IQR) 72 (53.5\u2013123.5) 77 (48\u2013113) 0.66 EMP54, counts/\u03bcL (IQR) 58 (39.5\u201378.5) 39 (18\u2013141) 0.42 EMP54-Lymphocyte Conjugates, MFI (IQR) 1.37 (1.26\u20131.42) 1.2 (1.13\u20131.26) 0.001 EMP54-Monocyte Conjugates, MFI (IQR) 1.14 (1.05\u20131.3) 1.22 (1.16\u20131.64) 0.08 EMP54-Neutrophil Conjugates, MFI (IQR) 1.46 (1.27\u20132.28) 1.66 (1.28\u20132.34) 0.74 EMP62E-Lymphocyte Conjugates, MFI (IQR) 1.15 (1.11\u20131.19) 1.13 (1.07\u20131.18) 0.13 EMP62E -Monocyte Conjugates, MFI (IQR) 1.17 (1.02\u20131.19) 1.31 (1.22\u20131.56) 0.0005 EMP62E -Neutrophil Conjugates, MFI (IQR) 1.47 (1.21\u20132.01) 1.94 (1.57\u20132.52) 0.10 . HIV+ Patients . Control . P value . MFI=Mean fluorescence intensity EMP31, counts/\u03bcL (IQR) 680 (497\u20131112) 1018 (566-1691) 0.16 EMP51, counts/\u03bcL (IQR) 114 (75\u2013141.5) 114 (96\u2013143) 0.59 EMP62E, counts/\u03bcL (IQR) 72 (53.5\u2013123.5) 77 (48\u2013113) 0.66 EMP54, counts/\u03bcL (IQR) 58 (39.5\u201378.5) 39 (18\u2013141) 0.42 EMP54-Lymphocyte Conjugates, MFI (IQR) 1.37 (1.26\u20131.42) 1.2 (1.13\u20131.26) 0.001 EMP54-Monocyte Conjugates, MFI (IQR) 1.14 (1.05\u20131.3) 1.22 (1.16\u20131.64) 0.08 EMP54-Neutrophil Conjugates, MFI (IQR) 1.46 (1.27\u20132.28) 1.66 (1.28\u20132.34) 0.74 EMP62E-Lymphocyte Conjugates, MFI (IQR) 1.15 (1.11\u20131.19) 1.13 (1.07\u20131.18) 0.13 EMP62E -Monocyte Conjugates, MFI (IQR) 1.17 (1.02\u20131.19) 1.31 (1.22\u20131.56) 0.0005 EMP62E -Neutrophil Conjugates, MFI (IQR) 1.47 (1.21\u20132.01) 1.94 (1.57\u20132.52) 0.10 View Large",
    "topics": [
        "antiretroviral therapy, highly active",
        "cell-derived microparticles",
        "earth microbiome project",
        "endothelium",
        "hiv infections",
        "leukocytes",
        "e-selectin",
        "intercellular adhesion molecule 1",
        "cancer",
        "cd31 antigens"
    ],
    "author_names": [
        "Jacques Simkins, MD",
        "Vicente F. Corrales-Medina, MD",
        "Julio A. Chirinos, MD",
        "Stephen Symes, MD",
        "Dushyantha T. Jayaweera, ND",
        "Luis Espinoza, MD",
        "Joaquin J. Jimenez, MD",
        "Wenche Jy, PhD",
        "Lawrence L. Horstman, BS",
        "Yeon-Soong Ahn, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Jacques Simkins, MD",
            "author_affiliations": [
                "Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Vicente F. Corrales-Medina, MD",
            "author_affiliations": [
                "Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Julio A. Chirinos, MD",
            "author_affiliations": [
                "Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stephen Symes, MD",
            "author_affiliations": [
                "Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Dushyantha T. Jayaweera, ND",
            "author_affiliations": [
                "Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luis Espinoza, MD",
            "author_affiliations": [
                "Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joaquin J. Jimenez, MD",
            "author_affiliations": [
                "Wallace H. Coulter Platelet Laboratory, Division og Hematology/Oncology"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Wenche Jy, PhD",
            "author_affiliations": [
                "Wallace H. Coulter Platelet Laboratory, Division og Hematology/Oncology"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lawrence L. Horstman, BS",
            "author_affiliations": [
                "Wallace H. Coulter Platelet Laboratory, Division og Hematology/Oncology"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Yeon-Soong Ahn, MD",
            "author_affiliations": [
                "Wallace H. Coulter Platelet Laboratory, Division og Hematology/Oncology"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-03T09:31:05",
    "is_scraped": "1"
}